Barclays’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$351K Sell
37,849
-40,638
-52% -$394K ﹤0.01% 3380
2025
Q4
$793K Buy
78,487
+22,491
+40% +$224K ﹤0.01% 3589
2025
Q3
$602K Buy
55,996
+2,213
+4% +$24.7K ﹤0.01% 3692
2025
Q2
$731K Buy
53,783
+3,118
+6% +$43.5K ﹤0.01% 3537
2025
Q1
$645K Sell
50,665
-14,341
-22% -$204K ﹤0.01% 3369
2024
Q4
$783K Buy
65,006
+53,527
+466% +$565K ﹤0.01% 3536
2024
Q3
$104K Buy
+11,479
New +$99.7K ﹤0.01% 4563

Other funds holding DCTH

Barclays's DCTH Position: Q1 2026 in Review

Barclays reduced its Delcath Systems (DCTH) stake by 52% in Q1 2026, selling an estimated $394K and leaving 37,849 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #3380.

Barclays first reported a position in DCTH in Q3 2024 and has held it in 7 quarters since. The position peaked at $793K in Q4 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Barclays held 37,849 shares of Delcath Systems worth $351K as of Q1 2026.
  • Barclays sold 40,638 Delcath Systems shares in Q1 2026, an estimated $394K.
  • Delcath Systems made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3380 holding.
  • Barclays first reported a position in Delcath Systems in Q3 2024 and has held it in 7 quarters since.
  • Barclays's Delcath Systems position peaked at $793K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.